Page last updated: 2024-10-21

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Respiratory Distress Syndrome

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with Respiratory Distress Syndrome in 1 studies

alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.

Respiratory Distress Syndrome: A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Klein, KU1
Johannes, A1
Brückner, M1
Thomas, R1
Matthews, S1
Frauenknecht, K1
Leukel, P1
Mazur, J1
Poplawski, A1
Muellenbach, R1
Sommer, CJ1
Thal, SC1
Engelhard, K1

Other Studies

1 other study available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Respiratory Distress Syndrome

ArticleYear
Systemic PaO2 Oscillations Cause Mild Brain Injury in a Pig Model.
    Critical care medicine, 2016, Volume: 44, Issue:5

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Blood Gas Analysis; Brain Injurie

2016